>
Pathway To Citizenship For DACA? Trump Directs DHS Chief To 'Work With Democrats'...
Department Of Labor Floats Stricter Rules For Unemployment Benefits
Baby it's cold INSIDE! Scientists create the coldest temperature ever recorded in the lab...
Dark horse Jim Jordan beats establishment pick Steve Scalise to lead House GOP after promising...
Musk's Starlink Is Building An Orbital Bypass As Undersea Cable Sabotage Threats Mount
A robot just built a structure in space for the first time
The Greatest Theft in Human History
3D-Printed Tungsten Survives 74 Fusion Plasma Discharges, Advancing the Engineering...
Dude turns a $23 used smartphone into the 4G brain of an RC aircraft.
China's World-Beating Supercar Just Hit 312 MPH
Pentagon Delivers 25,000+ Drones And Counter-Drone Systems To CENTCOM In A "Massive Surge"
Prism puts an eye-controlled Linux computer on your face
Remember Yesterday: AI For Today and Tomorrow
Robot Mowers Invade America's Golf Courses, Putting Groundskeepers On Notice

In 2013, GlaxoSmithKline shutdown Sirtris (David Sinclair's company) about five years after spending $720 million to buy Sirtris.
David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
Life Biosciences was co-founded in 2017 by David A. Sinclair, PhD, AO, a professor in the Department of Genetics at Harvard Medical School, and Tristan Edwards, an investment professional who developed its innovative company structure.